As of 2025-01-21, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 34.82 USD. This relative valuation is based on P/E multiples. With the latest stock price at 118.00 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -70.5%.
The range of the Relative Valuation is 24.44 - 53.40 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 41.9x | 34.6x |
| Forward P/E multiples | 19.2x - 32.0x | 20.0x |
| Fair Price | 24.44 - 53.40 | 34.82 |
| Upside | -79.3% - -54.7% | -70.5% |
| Date | P/E |
| 2025-01-17 | 92.51 |
| 2025-01-16 | 91.77 |
| 2025-01-15 | 93.55 |
| 2025-01-14 | 93.16 |
| 2025-01-13 | 92.84 |
| 2025-01-10 | 97.83 |
| 2025-01-08 | 98.99 |
| 2025-01-07 | 97.59 |
| 2025-01-06 | 100.26 |
| 2025-01-03 | 99.00 |
| 2025-01-02 | 97.28 |
| 2024-12-31 | 95.32 |
| 2024-12-30 | 95.01 |
| 2024-12-27 | 95.25 |
| 2024-12-26 | 96.72 |
| 2024-12-24 | 95.56 |
| 2024-12-23 | 94.59 |
| 2024-12-20 | 93.27 |
| 2024-12-19 | 93.66 |
| 2024-12-18 | 94.27 |
| 2024-12-17 | 98.59 |
| 2024-12-16 | 99.40 |
| 2024-12-13 | 96.98 |
| 2024-12-12 | 97.58 |
| 2024-12-11 | 98.30 |
| 2024-12-10 | 99.33 |
| 2024-12-09 | 101.13 |
| 2024-12-06 | 100.48 |
| 2024-12-05 | 99.00 |
| 2024-12-04 | 99.19 |
| 2024-12-03 | 98.79 |
| 2024-12-02 | 100.31 |
| 2024-11-29 | 104.53 |
| 2024-11-27 | 108.14 |
| 2024-11-26 | 102.31 |
| 2024-11-25 | 89.88 |
| 2024-11-22 | 89.55 |
| 2024-11-21 | 86.63 |
| 2024-11-20 | 86.91 |
| 2024-11-19 | 83.58 |
| 2024-11-18 | 82.06 |
| 2024-11-15 | 81.95 |
| 2024-11-14 | 85.54 |
| 2024-11-13 | 88.18 |
| 2024-11-12 | 89.62 |
| 2024-11-11 | 92.38 |
| 2024-11-08 | 95.34 |
| 2024-11-07 | 94.40 |
| 2024-11-06 | 100.32 |
| 2024-11-05 | 98.00 |